Medicine
Sevelamer 2400 mg powder for oral suspension
Sevelamer 2400 mg powder for oral suspension is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 15° to 30°C (59° to 86°F). Protect from moisture.
Key facts
- Active ingredient (INN)
- Sevelamer
- Brand
- Sold under the generic name
- Strength
- 2400 mg
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 90 pouches, 90 packets and 3 more
- Manufacturers
- Aurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaMacleods PharmaceuticalsIndiaAmneal Pharmaceuticals of New YorkBionpharmaSanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Store at 15° to 30°C (59° to 86°F). Protect from moisture.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- V03AE02 Sevelamer
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 June 2017
- Identifiers
- RxCUI 861370, 861375, 749206DailyMed set ID c3cf4807-ae5f-528e-e053-2a95a90ac640, de172c3d-17eb-3489-35fb-370a0893b663, 3abc32fe-1bfc-4759-8f7c-36095e221b06 +3NDC 69452-127, 43598-479, 0955-1054 +3Application ANDA209374, ANDA210464, NDA022318 +3
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 90 pouch in 1 carton / 1 powder, for suspension in 1 pouch | 65862-931-90 | Aurobindo PharmaIndia | 13 June 2017 |
| 90 packet in 1 carton / 1 powder, for suspension in 1 packet | 43598-479-90 | Dr. Reddy's LaboratoriesIndia | 25 October 2018 |
| 90 packet in 1 carton / 1 powder, for suspension in 1 packet | 33342-289-68 | Macleods PharmaceuticalsIndia | 26 April 2024 |
| 90 packet in 1 carton / 1 powder, for suspension in 1 packet | 0115-1366-29 | Amneal Pharmaceuticals of New York | 20 November 2020 |
| 90 packet in 1 carton / 1 powder, for suspension in 1 packet | 69452-127-19 | Bionpharma | 1 October 2021 |
| 90 packet in 1 box / 1 powder, for suspension in 1 packet | 0955-1054-90 | Sanofi-Aventis | 1 January 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Sevelamer 2400 mg powder for oral suspension.
Other strengths and forms of Sevelamer
Clinical summary
Sevelamer is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. MedsAcross supplies Sevelamer for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about SevelamerFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Renvela prescribing information (Genzyme) · U.S. National Library of Medicine, DailyMed
- Renagel: European public assessment report (EPAR) · European Medicines Agency
- Renvela: European public assessment report (EPAR) · European Medicines Agency
Need Sevelamer 2400 mg powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.